Alector
Focus: Alector is a South San Francisco-based biotechnology company focused on developing monoclonal antibody treatments for Alzheimer's disease and other neurodegenerative conditions. The company operates as a pre-revenue or early-stage biotech with a pipeline centered on neuroinflammation and neurodegeneration.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
2
Should You Work at Alector?
AI assessmentAlector offers meaningful exposure to cutting-edge neurobiology and antibody development but carries execution and funding stability risks typical of pre-revenue biotech.
Why Work Here
- Pipeline depth in high-value neurology space with 5 active programs spanning Phase 1–3, including Latozinemab in Phase 3 for neurodegenerative diseases
- Focused therapeutic area (Alzheimer's antibodies) allows deep expertise building in a mission-driven disease area with strong unmet medical need
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AL003
Alzheimer DiseaseClinical Trials (1)
NCT03822208First in Human Study for Safety and Tolerability of AL003.
Phase 1Help build intelligence for Alector
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.